Net Income (Loss) Attributable to Parent in USD of Peak Bio, Inc. from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Peak Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2020 to Q3 2024.
  • Peak Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2024 was $1.71M, a 317% increase year-over-year.
  • Peak Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2024 was -$3.32M, a 82.6% increase year-over-year.
  • Peak Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12.8M, a 2.01% increase from 2022.
  • Peak Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.1M, a 57.7% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Peak Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.32M $1.71M +$1.3M +317% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 -$4.63M -$2.08M +$3.87M +65% 01 Apr 2024 30 Jun 2024 10-Q 23 Aug 2024
Q1 2024 -$8.49M -$2.43M +$4.33M +64% 01 Jan 2024 31 Mar 2024 10-Q 23 Aug 2024
Q4 2023 -$12.8M -$525K +$6.23M +92.2% 01 Oct 2023 31 Dec 2023 10-K 06 Aug 2024
Q3 2023 -$19.1M $411K +$2.12M 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$21.2M -$5.94M -$3.42M -136% 01 Apr 2023 30 Jun 2023 10-Q 23 Aug 2024
Q1 2023 -$17.8M -$6.77M -$4.67M -222% 01 Jan 2023 31 Mar 2023 10-Q 23 Aug 2024
Q4 2022 -$13.1M -$6.75M +$1.94M +22.3% 01 Oct 2022 31 Dec 2022 10-K 06 Aug 2024
Q3 2022 -$15M -$1.71M -$1.83M -1511% 01 Jul 2022 30 Sep 2022 10-Q 25 Jun 2024
Q2 2022 -$13.2M -$2.52M -$3.14M -509% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023
Q1 2022 -$10.1M -$2.1M -$1.75M -507% 01 Jan 2022 31 Mar 2022 10-Q 12 Jul 2023
Q4 2021 -$8.3M -$8.69M 01 Oct 2021 31 Dec 2021 10-Q 18 Aug 2023
Q3 2021 $121K +$122K 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022
Q2 2021 $616K 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$346K 01 Jan 2021 31 Mar 2021 10-Q 19 May 2022
Q3 2020 -$310* 06 Aug 2020 30 Sep 2020 10-Q 15 Nov 2021

Peak Bio, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.8M +$263K +2.01% 01 Jan 2023 31 Dec 2023 10-K 06 Aug 2024
2022 -$13.1M -$4.79M -57.7% 01 Jan 2022 31 Dec 2022 10-K 06 Aug 2024
2021 -$8.3M 01 Jan 2021 31 Dec 2021 10-Q 18 Aug 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.